Le terapie ossidative con ozono come soluzione alla crisiemergente nella gestione delle malattie infettive.

Sono il Dr Alessio Bernardini ed oggi commenterò riassumendo questo studio che affronta una problematica emergente nella gestione delle malattie infettive, in

particolare la crisi dovuta alla resistenza agli antibiotici e alla comparsa di "superbatteri" e virus letali come l'Ebola. Si evidenzia come migliaia di persone stiano morendo a causa di malattie che un tempo erano facilmente trattabili. In questo contesto, l'ozonoterapia viene proposta come una soluzione sicura, economica ed efficace, poiché non è un antibiotico e i microbi non sviluppano resistenza ad essa.

L'ozonoterapia

è un trattamento studiato a lungo e si è dimostrato efficace contro diverse infezioni batteriche e virali, inclusa l'Ebola. Essa agisce come un potente germicida e migliora vari

parametri fisiologici essenziali per la difesa contro le infezioni. Nonostante questi benefici, l'ozonoterapia non viene considerata nella medicina convenzionale principalmente perché non può essere brevettata e quindi non rappresenta un'opzione commercialmente redditizia per l'industria farmaceutica.

La storia dell'ozono

risale a oltre un secolo fa, quando venne scoperto e utilizzato per la purificazione dell'acqua e il trattamento di malattie. Tuttavia, con l'avvento degli antibiotici, queste terapie ossidative, tra cui anche la terapia con raggi ultravioletti e il perossido di idrogeno intravenoso, sono state in gran parte dimenticate.

Uno dei punti chiave dello studio è che i batteri non sono riusciti a sviluppare resistenza ai germicidi naturali come l'ozono e la luce ultravioletta. Questo perché il sistema immunitario umano risponde alle infezioni generando forti ossidanti, come il perossido di idrogeno e i radicali liberi dell’Ossigeno, che distruggono gli agenti patogeni.

Nell'ambito dell'attuale crisi sanitaria globale, con la diffusione dell'Ebola e altre infezioni difficili da trattare, lo studio suggerisce che l'ozonoterapia potrebbe fornire una risposta efficace. In Sierra Leone, durante l'epidemia di Ebola, l'ozonoterapia ha portato a recuperi completi in tutti i pazienti trattati, dimostrando il suo potenziale in situazioni critiche. Tuttavia, l'ozonoterapia è ostacolata da varie barriere, come la mancanza di studi finanziati dall'industria e le restrizioni imposte dalle autorità sanitarie. Nonostante queste difficoltà, i risultati clinici e l'assenza di effetti collaterali significativi la rendono una terapia da considerare seriamente nella gestione delle malattie infettive. Lo studio conclude affermando che la medicina moderna dovrebbe tornare a considerare terapie ossidative come l'ozonoterapia, specialmente nei paesi in via di sviluppo o in situazioni di emergenza, dove gli antibiotici falliscono.

In sintesi, questo studio sottolinea l'importanza di esplorare alternative agli antibiotici, come l'ozonoterapia, per far fronte alla crescente crisi sanitaria causata dalla resistenza agli antibiotici e dalle infezioni virali letali.

REFERENZE STUDIO

1. Graham DW, Knapp CW, Christensen BT, McCluskey S, Dolfing J. Appearance of beta-lactam

resistance genes in agricultural soils and clinical isolates over the 20th century Sci Rep.

2016;6:21550

• Cited Here

2. Bjarnsholt T. The role of bacterial biofilms in chronic infections APMIS Suppl. 2013:1–51

• Cited Here

3. Khondker A, Dhaliwal AK, Saem S, et al Membrane charge and lipid packing determine

polymyxin-induced membrane damage Commun Biol. 2019;2:67

• Cited Here

4. Cohut M Why antibiotics fail in the fight against bacteria.Accessed by 2019-11-11 https://

www.medicalnewstoday.com/articles/324479.php

• Cited Here

5. Clinical Research Support Center, Office of Regulatory Compliance, University of Colorado. The

Clinical Use of non-FDA-Approved Drugs and Devices (Includes the terms “Emergency Use,”

“Compassionate Use,” “Expanded Access,” and “Right to Try”).Accessed by 2019-11-11 http://

www.ucdenver.edu/research/ResearchAreas/Documents/

Emergency%20Use%20Tip%20Sheet_pdf.pdf

• Cited Here

6. Goodwin JS, Goodwin JM. The tomato effect Rejection of highly efficacious therapies JAMA.

1984;251:2387–2390

• Cited Here

7. Babior BM, Takeuchi C, Ruedi J, Gutierrez A, Wentworth P Jr. Investigating antibody-catalyzed

ozone generation by human neutrophils Proc Natl Acad Sci U S A. 2003;100:3031–3034

• Cited Here

8. Nikola T Apparatus For Producing Ozone US Patents US568177A 1896.

• Cited Here

9. Naik SV, K R, Kohli S, Zohabhasan S, Bhatia S. Ozone- a biological therapy in dentistry- reality

or myth Open Dent J. 2016;10:196–206

• Cited Here

10. Mayer RLaRaus J. Experiences of a pediatrician using ozone as a chemotherapeutic abent for

the treatment of diseases in children Medical Applications of Ozone: International Ozone

Association, Pan American Committee. 1983:210

• Cited Here

11. Bocci V OZONE: A new medical drug. 20112nd ed Springer

• Cited Here

12. Menéndez SA, Weiser MT Advances of Ozone Therapy in Medicine and Dentistry Santa. 2016

Barbara, CA, USA Ozone Therapies Group

• Cited Here

13. Zamora Z, Schulz S, González YC, Menéndez-Cepero S. Intraperitoneal application of ozone

in a postoperative sepsis model in rats Rev Mex Cienc Farm. 2002;33:13–17

• Cited Here

14. Bette M, Nusing RM, Mutters R, Zamora ZB, Menendez S, Schulz S. Efficiency of tazobactam/

piperacillin in lethal peritonitis is enhanced after preconditioning of rats with O3/O2-

pneumoperitoneum Shock. 2006;25:23–29

• Cited Here

15. Zamora ZB, Borrego A, López OY, et al Effects of ozone oxidative preconditioning on TNFalpha

release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock

Mediators Inflamm. 2005;2005:16–22

• Cited Here

16. Belianin II, Shmelev EI. Blood ozonation in the treatment of patients with progressive

pulmonary tuberculosis concurrent with diabetes mellitus Probl Tuberk. 1998:30–33

• Cited Here

17. Belianin II. The action of blood ozonization on the course of progressive pulmonary

tuberculosis combined with diabetes mellitus Ter Arkh. 1997;69:44–48

• Cited Here

18. Lee JE, Saphire EO. Ebolavirus glycoprotein structure and mechanism of entry Future Virol.

2009;4:621–635

• Cited Here

19. Kekez MM, Sattar SA. A new ozone-based method for virus inactivation: preliminary study

Phys Med Biol. 1997;42:2027–2039

• Cited Here

20. Shin GA, Sobsey MD. Reduction of Norwalk virus, poliovirus 1, and bacteriophage MS2 by

ozone disinfection of water Appl Environ Microbiol. 2003;69:3975–3978

• Cited Here

21. Herb K, Flehmig B, Botzenhart K. Comparison of ozone inactivation, in flowing water, of

hepatitis A virus, poliovirus 1, and indicator organisms Appl Environ Microbiol. 1989;55:2949–2953

• Cited Here

22. Emerson MA, Sproul OJ, Buck CE. Ozone inactivation of cell-associated viruses Appl Environ

Microbiol. 1982;43:603–608

• Cited Here

23. Katzenelson E, Koerner G, Biedermann N, Peleg M, Shuval HI. Measurement of the

inactivation kinetics of poliovirus by ozone in a fast-flow mixer Appl Environ Microbiol.

1979;37:715–718

• Cited Here

24. Mirazimi A, Mousavi-Jazi M, Sundqvist VA, Svensson L. Free thiol groups are essential for

infectivity of human cytomegalovirus J Gen Virol. 1999;80:2861–2865

• Cited Here

25. Roy D, Wong PK, Engelbrecht RS, Chian ES. Mechanism of enteroviral inactivation by ozone

Appl Environ Microbiol. 1981;41:718–723

• Cited Here

26. Ryser HJ, Levy EM, Mandel R, DiSciullo GJ. Inhibition of human immunodeficiency virus

infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction

Proc Natl Acad Sci U S A. 1994;91:4559–4563

• Cited Here

27. Leusink J, Kraft G Antimicrobial effects of ozonated water against generic Ecoli on swine

intestines varying ozone concentrations and exposure times.Accessed by 2019-11-11 https://

wwwozonesolutionscom/pub/media/Antimicrobial-Effects-of-Ozonated-Water-Against-Generic-

Ecoli-on-Swine-Intestinespdf

• Cited Here

28. Schmidt H. Regelsberger’s intravenous oxygen therapy--an interpretation of results in practice

from a biochemical and physiological point of view Forsch Komplementarmed Klass Naturheilkd.

2002;9:7–18

• Cited Here

29. Verrazzo G, Coppola L, Luongo C, et al Hyperbaric oxygen, oxygen-ozone therapy, and

rheologic parameters of blood in patients with peripheral occlusive arterial disease Undersea

Hyperb Med. 1995;22:17–22

• Cited Here

30. Schulz S, Ninke S, Watzer B, Nusing RM. Ozone induces synthesis of systemic prostacyclin by

cyclooxygenase-2 dependent mechanism in vivo Biochem Pharmacol. 2012;83:506–513

• Cited Here

31. Chaitidis P, Kreutzer FJ, Gerth C, Janata P, Kuhn H. Impact of intravenous oxygen therapy on

the expression of reticulocyte-type 15-lipoxygenase in human volunteers Prostaglandins Leukot

Essent Fatty Acids. 2004;71:271–276

• Cited Here

32. World Conference on Ozone Therapy in Medicine DaV. 2017 Ancona, Italy

• Cited Here

33. Barnes RL, Caskey DK Using ozone in the prevention of bacterial biofilm forming and

scaling.Accessed by 2019-11-11 http://wwwprozoneintcom/pdf/biofilmspdf

• Cited Here

34. Bialoszewski D, Pietruczuk-Padzik A, Kalicinska A, et al Activity of ozonated water and ozone

against Staphylococcus aureus and Pseudomonas aeruginosa biofilms Med Sci Monit.

2011;17:BR339–344

• Cited Here

35. Jacobs M Zwischenfalle und typische Komplikationen in der Ozone-Sauerstoff-Therapie

OzoNachrichten. 1982

• Cited Here

36. Rowen R. Ultraviolet blood irradiation therapy (photo-oxidation) the cure that time forgot Int J

Biosocial Med Res. 1996;14:115–132

• Cited Here

37. Miley G, Christensen JA. Ultraviolet blood irradiation therapy; further studies in acute infections

Am J Surg. 1947;73:486–493

• Cited Here

38. Oliver TH, Cantab BC, Murphy DV. Influenzal pneumonia: the intravenous injection of hydrogen

peroxide Lancet. 1920;1:432–433

• Cited Here

39. Chen Q, Espey MG, Krishna MC, et al Pharmacologic ascorbic acid concentrations selectively

kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues Proc Natl Acad Sci U

S A. 2005;102:13604–13609

• Cited Here

40. Smith L Clinical Guide to the Use of Vitamin C The Clinical Experiences of Frederick R Klenner,

MD 1988.Accessed by 2019-11-11 https://wwwseanetcom/~alexs/ascorbate/198x/smith-lhclinical_

guide_1988htm

• Cited Here

41. Rowen R, Robins H, Carew K, Kamara M, Jalloh M. Rapid resolution of hemorrhagic fever

(Ebola) in Sierra Leone with ozone therapy Afr J Infect Dis. 2016;10:49–54

• Cited Here

42. Wilson HW, Amo-Addae M, Kenu E, Ilesanmi OS, Ameme DK, Sackey SO. Post-Ebola

syndrome among Ebola virus disease survivors in Montserrado County, Liberia 2016 Biomed Res

Int. 2018;2018:1909410

• Cited Here

43. Tiffany A, Vetter P, Mattia J, et al Ebola virus disease complications as experienced by

survivors in Sierra Leone Clin Infect Dis. 2016;62:1360–1366

• Cited Here

44. Rowen RJ. Ozone therapy as a primary and sole treatment for acute bacterial infection: case

report Med Gas Res. 2018;8:121–124

• Cited Here

45. Rowen RJ. Ozone therapy in conjunction with oral antibiotics as a successful primary and sole

treatment for chronic septic prosthetic joint: review and case report Med Gas Res. 2018;8:67–71

• Cited Here

46. Rowen RJ. Remission of aggressive autoimmune disease (dermatomyositis) with removal of

infective jaw pathology and ozone therapy: review and case report Auto Immun Highlights.

2018;9:7

• Cited Here

47. Bocci V, Paulesu L. Studies on the biological effects of ozone 1 Induction of interferon gamma

on human leucocytes Haematologica. 1990;75:510–515

• Cited Here

48. Saini R. Ozone therapy in dentistry: A strategic review J Nat Sci Biol Med. 2011;2:151–153

• Cited Here

49. Andikyan VM, Voloshchuk IN, Kovganko PA, Clemente JM. Morphofunctional changes in the

placenta after ozone therapy Bull Exp Biol Med. 2000;130:715–718

• Cited Here

50. Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A. Lyme disease: an infectious and

postinfectious syndrome J Rheumatol. 1994;21:454–461

• Cited Here

51. Shadick NA, Phillips CB, Logigian EL, et al The long-term clinical outcomes of Lyme disease A

population-based retrospective cohort study Ann Intern Med. 1994;121:560–567

• Cited Here

52. Dersch R, Sarnes AA, Maul M, et al Quality of life, fatigue, depression and cognitive

impairment in Lyme neuroborreliosis J Neurol. 2015;262:2572–2577

• Cited Here

53. Aucott JN, Rebman AW, Crowder LA, Kortte KB. Post-treatment Lyme disease syndrome

symptomatology and the impact on life functioning: is there something here? Qual Life Res.

2013;22:75–84